Drug Shortage Report for MYLAN-VERAPAMIL SR
Report ID | 188108 |
Drug Identification Number | 02450496 |
Brand name | MYLAN-VERAPAMIL SR |
Common or Proper name | VERAPAMIL SR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT, 500BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-07 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-03-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-03-27 | French | Compare |
v1 | 2023-03-27 | English | Compare |
Showing 1 to 2 of 2